杭州启明医疗器械股份有限公司 VENUS MEDTECH (HANGZHOU) INC. Mediaroom

Venus Medtech Hosts Inaugural Global Partner Summit in Paris

Company highlights international growth strategy, expanding structural heart portfolio, and commerc...

2026-05-26 15:00 3789

Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025...

2025-11-17 17:00 1662

Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 20...

2025-10-25 15:00 3256

Court Sides with Cardiovalve in Edwards patent spat

HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock...

2025-08-05 20:00 2464

Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations

HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, herei...

2025-04-22 09:00 4587

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

HANGZHOU, China, Sept. 5, 2024 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500....

2024-09-05 16:56 3407

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

HANGZHOU, China, June 14, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of int...

2024-06-14 15:15 4171

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

HANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of inte...

2024-02-05 21:00 3626

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

The company will be presenting its growing pipeline of superb technologies for treating all four he...

2023-11-20 07:09 3329

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally

HANGZHOU, China, Aug. 7, 2023 /PRNewswire/ -- Recently, Venus Medtech (Hangzhou ) Inc. ("Venus Medte...

2023-08-07 08:20 4053

VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally

Confirmatory clinical trial of Liwen RF™ ablation system in China concluded

HANGZHOU, China, March 6, 2023 /PRNewswire/ -- On March 3, Venus Medtech ( Hangzhou) Inc. (Venus Med...

2023-03-06 07:29 3608

Confirmatory clinical trial of Liwen RF™ ablation system in China concluded

Venus Medtech to showcase its structural heart treatments at London Valves 2022

The company's growing number of solutions for structural heart disease will be presented at multipl...

2022-11-25 18:08 8088

Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence

HANGZHOU, China, Sept. 1, 2022 /PRNewswire/ -- On August 31, 2022, Venus Medtech (Hangzhou) Inc. (2...

2022-09-01 20:55 4967

Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

HANGZHOU, China, Dec. 8, 2021 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK...

2021-12-08 08:28 4847

Latest News